Analytical evaluation of thirty-two severe acute respiratory syndrome 2 lateral flow antigen tests demonstrates sensitivity remains with the SARS-CoV-2 Gamma lineage.

Nadia Kontogianni, Daisy Bengey, Dom Wooding, Katie Buist, Caitlin Greenland-Bews, Chris Williams, Margaretha de Vos, Victor Santana Santos, Camille Escadafal, Emily Adams, Thomas Edwards, Ana Isabel Cubas-Atienzar

Research output: Contribution to journalArticlepeer-review

Abstract

Background:

The emergence of variants of concern (VOCs) requires an ongoing assessment of the performance of antigen lateral flow tests (Ag-RDTs). The limit of detection (LOD) of 32 Ag-RDTs was evaluated using the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Gamma variant.

Methods:

Ag-RDTs were performed according to the manufacturer’s instructions with a clinical isolate of the Gamma variant.

Results:

Twenty-eight of the 32 Ag-RDTs exceeded the World Health Organization criteria.

Conclusions:

This comprehensive analytical evaluation of Ag-RDTs demonstrated that the test performance was maintained with Gamma VOC.

Original languageEnglish
Article numbere0016-2022
Pages (from-to)e0016
JournalRevista da Sociedade Brasileira de Medicina Tropical
Volume55
DOIs
Publication statusPublished - 6 Jun 2022

Keywords

  • Diagnostic tests
  • SARS-CoV-2
  • SARS-CoV-2 Gamma variant
  • Variant of concern

Fingerprint

Dive into the research topics of 'Analytical evaluation of thirty-two severe acute respiratory syndrome 2 lateral flow antigen tests demonstrates sensitivity remains with the SARS-CoV-2 Gamma lineage.'. Together they form a unique fingerprint.

Cite this